InhaleRx Limited (ASX:IRX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0250
0.00 (0.00%)
May 8, 2025, 4:10 PM AEST

InhaleRx Revenue

In the year 2024, InhaleRx had annual revenue of 401.81K AUD, down -66.63%. InhaleRx had revenue of 280.42K in the half year ending December 31, 2024, with 1,030.71% growth.

Revenue
401.81K
Revenue Growth
-66.63%
P/S Ratio
13.28
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.34M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024401.81K-802.24K-66.63%
Dec 31, 20231.20M1.18M4,755.02%
Dec 31, 202224.80K-156.94K-86.35%
Dec 31, 2021181.74K159.61K721.35%
Dec 31, 202022.13K-110.85K-83.36%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 24.61B
Pro Medicus 184.58M
Cochlear 2.31B
Sonic Healthcare 9.33B
Telix Pharmaceuticals 783.21M
Ramsay Health Care 17.12B
Ansell 3.00B
Regis Healthcare 1.10B
Revenue Rankings